His lab is focusing on refining the alanine-scanning assay to a few essential residues that will properly distinguish between fibrils from neurodegenerative tauopathies. He envisions using this streamlined assay for postmortem neuropathological analysis, And perhaps for blood screening of tauopathies.In this particular assay, scientists include ext